Pharma’s response to the 2020 pandemic

Potential to accelerate patient care beyond COVID-19

2020 was a year that tested individual limits yet provided an enormous opportunity to come together as a global community to tackle a common enemy − including the rapid, coordinated response of the pharmaceutical industry, spanning regulators, non-profit organizations, governments large and small, commercial organizations, academic institutions and the general public. Together, we quickly began to understand the novel coronavirus, evaluated and deployed treatments, developed and manufactured vaccines in record time, locked down and dissolved barriers to collaboration.

In this report, we reflect on some of the changes brought about by the COVID-19 pandemic and discuss how these could change patient care forever.

Fill out the form to get your copy now!